The first definitive/adult-type hematopoietic stem cells (HSCs) in the mouse aorta-gonad-mesonephros region emerge between embryonic days 10.5 and 11.5. The discovery of clusters of hematopoietic cells on the ventral luminal surface of the dorsal aorta in various vertebrate species has led to speculation that the floor of the dorsal aorta may play an essential role for the development of the definitive hematopoietic system. Here, we functionally show affiliation of definitive HSCs with the ventral floor of the dorsal aorta, whereas colony-forming hematopoietic activity is associated with both ventral and dorsal domains. We show that a rare population of PECAM1 high CD45 ؉ cells, within which definitive HSCs reside, is predominantly localized to intraaortic clusters. Furthermore, using ex vivo culture analysis, we demonstrate that the ventral domain of the dorsal aorta has an exclusive functional capacity of inducing and expanding definitive HSCs.
D
uring mouse embryonic development, the first definitive transplantable high-level repopulating hematopoietic stem cells (HSCs) emerge by embryonic day (E) 10.5-11.5 (1) (2) (3) (4) . At this stage, the aorta-gonad-mesonephros (AGM) region is capable of autonomous initiation and expansion of HSCs, indicating its important role in the development of the definitive hematopoietic system (2) . HSCs first appear in the dorsal aorta (Ao), which consists of endothelial and mesenchymal components, and slightly later in the urogenital ridges (UGR) (5, 6) . The presence of clusters of hematopoietic cells attached to the ventral endothelial lining of the developing Ao in various vertebrate species (7) (8) (9) (10) (11) has been suggested to be a morphological manifestation of hematopoietic progenitor/stem cell development; a view further supported by experimental studies of the relationship between endothelial cells and hematopoietic progenitors/stem cells in the AGM region (10, (12) (13) (14) (15) (16) (17) (18) .
To date, no direct evidence has been produced in support of the dorsoventral polarity in hematopoietic development within the Ao. Here, we subdissected the E10.5-11.5 Ao into the ventral (AoV) and dorsal (AoD) domains and tested this hypothesis directly by using robust functional assays (for experimental design see Fig. 1 ). We demonstrate that in contrast to clonogenic hematopoietic progenitors, which are present in both the AoD and the AoV, definitive HSCs are localized predominantly to the AoV. Flow cytometric analysis supported by immunofluorescent confocal microscopy strongly suggests that HSCs in the E11.5 AGM reside in ventral intraaortic clusters. Furthermore, using the explant culture system, we show that, in contrast to the AoD, the AoV is capable of autonomous initiation and expansion of HSCs.
Results
Phenotypic Characterization of Dorsoventral Hematopoietic Polarity in the E11.5 Dorsal Aorta. On inspection of histological images obtained from transverse sections of E11.5 embryos, we noticed that small intraaortic cell clusters associated with hematopoietic activity are attached not only ventrally to the endothelial lining of the Ao as described (7) (8) (9) (10) (11) , but also on occasions to the lateral and dorsal endothelial lining ( Fig. 2 and Fig. 3B ).
We and others showed that in the E11.5 AGM region HSCs and CFU-Cs with high frequency reside within the VEcadherin ϩ CD45 ϩ population (12, 16) and also express PECAM1 (12, 16) . Here, we show that only PECAM1 high CD45 ϩ , but not PECAM1 low CD45
ϩ , cells coexpress VE-cadherin (Fig. 3A) . Therefore, HSCs emerging in the E11.5 AGM can be defined by a PECAM1 high CD45 ϩ phenotype; to localize these cells in the Ao, we performed immunofluorescent confocal microscopy analysis. We found that PECAM1 high CD45 ϩ cells are almost exclusively associated with the luminal surface of aortic endothelium and are usually incorporated within intraaortic clusters with occasional integration into the endothelial layer ( Fig. 3 B-E) . Inspection of whole-mount preparations of the dorsal aortae, enabling a more complete analysis of the luminal surface, readily identified PECAM1 high CD45 ϩ cells scattered on the floor but not in subendothelial mesenchymal layers of the dorsal aorta [ Given that hematopoietic cells are present in both dorsal and ventral domains of the Ao, we functionally investigated the dorsoventral distribution of in vitro hematopoietic progenitors (colony-forming units-culture, CFUCs) using the standard in vitro methylcellulose assay. We first measured the CFU-C content within the Ao and UGRs. To this end, the E11.5 Ao was separated from the UGRs (Fig. 5 A and  B) and, after preparation of cell suspensions, assayed in the methylcellulose culture. We found that CFU-Cs within the E11.5 AGM region are predominantly concentrated in the Ao. The isolated E11.5 Ao harbored 41 Ϯ 7.7 CFU-C, whereas the UGR contained only 18 Ϯ 6.5 CFU-Cs (as assessed per 0.5 embryo equivalent, e.e.) (P Ͻ 0.03) (Fig. 5I and SI Table 1 ).
To examine the dorsoventral distribution of CFU-Cs, the E11.5 Ao was bisected along the midline, resulting in the separation of the organ into AoD and AoV domains ( (SI Table 2 ). Consistent with the observation that a larger number of intraaortic clusters are present on the ventral domain, flow cytometric data showed a predominant presence of HSCenriched PECAM1
high CD45 ϩ cells in the AoV compared with AoD (Fig. 5H ). In the methylcellulose assay, the absolute numbers of CFU-Cs present in the AoD and the AoV are not significantly different (18 Ϯ 4.4 and 25 Ϯ 5.7, respectively) ( Fig.   5I and SI Table 1 ). On the basis of these data, a marked hematopoietic polarity along the dorsoventral axis of the E11.5 Ao is not obvious.
Because hematopoietic cells are highly migratory, direct assessment of CFU-C content in the AoD and the AoV may not give an accurate indication of their origin. Therefore, we examined the potential of the AoD and the AoV to develop CFU-Cs independently using an explant culture system as a model for the in vivo expansion of hematopoietic stem/progenitor cells (2, 4, 5, 16) . In these culture conditions, the isolated E11.5 Ao is capable of a modest expansion of CFU-Cs ( Fig. 5I and SI Table 3 ). However, when cultured separately, the AoD and the AoV perform very differently. The isolated AoD was unable to sustain CFU-Cs; a decrease in CFU-C number from 18 Ϯ 4.4 to 5.4 Ϯ 0.7 was observed during the 72-h culture period ( Fig. 5I and SI Table 3 ). Of note, no BFU-E were maintained during culture, and CFU-GEMM were rarely present. In contrast, culture of isolated AoV for 72 h resulted in an increase in CFU-C number from 25 Ϯ 5.7 to 44 Ϯ 2.8 ( Fig. 5I and SI Table 3 ) (P Ͻ 0.04), with all CFU-C types being preserved or expanded, suggesting a specific role for the AoV in the appearance of clonogenic hematopoietic progenitors.
Interestingly, despite the relatively even dorsoventral distribution of CFU-Cs in the Ao, the AoV has an exclusive and considerable capacity to expand CFU-Cs. Because CFU-Cs emerge in the embryo significantly earlier during development (19) (20) (21) , it has yet to be established whether the AoV induces development of CFU-C locally or expands progenitors that have migrated to the region from elsewhere e.g., the yolk sac.
Similar analysis at earlier stage (E10.5) revealed no significant dorsoventral polarity in the capacity to maintain/ expand CFU-Cs in the Ao (data not shown).
Definitive HSCs Are Localized to the AoV. Development of CFU-Cs is not specific to AGM hematopoiesis because a large number of these progenitors originate from the early yolk sac and are disseminated through the peripheral circulation (20) . Therefore, we turned to the analysis of definitive HSCs emerging in the AGM region. Consistent with previous observations, we found that the first emerging HSCs were localized almost exclusively to the E11.5 Ao but not to the UGR (5). Of seven mice that received cells from the Ao, five were successfully repopulated at 12 weeks after injection; in contrast, only one of seven mice that received transplants of UGR was repopulated ( Fig. 6 A and B) .
To examine the dorsoventral distribution of HSCs, E11.5 Ao were bisected and cells prepared from either AoD or AoV injected into irradiated adult mice (2.0 e.e. per recipient). We found that HSCs are localized almost exclusively to the AoV (Fig. 6C) : of 12 mice that received AoD only 1 mouse was reconstituted, whereas, of 13 mice transplanted with AoV, 11 were reconstituted (Fig. 6C) .
AoV Is an Exclusive and Functional Niche for HSCs in the Developing
Dorsal Aorta. As shown above, HSCs are localized to the AoV, which is consistent with the idea of a ventral niche in the Ao. Although HSC localization is indicative, it does not alone provide proof for the functional importance of the AoV as a niche, given the migratory nature of hematopoietic cells. Therefore, we examined whether the AoV was able to induce/initiate the development of HSCs. To this end, we analyzed the E10.5 stage, at which high-level adult repopulating HSCs are generally absent (1-4). At E10.5, the AGM region is capable of an autonomous initiation of HSCs, as shown by ex vivo culture experiments (2). The E10.5 Ao was therefore bisected into AoD and AoV, cultured ex vivo for 72 h, and transplanted into irradiated adult recipients. Our results revealed the exclusive capacity of isolated AoV to initiate HSCs: 5 of 10 mice that received 2.0 e.e. of cultured E10.5 AoV were successfully reconstituted; in contrast, none of the 10 mice that received cells from AoD cultures demonstrated hematopoietic chimerism (Fig. 7A) .
By E11.5, the AGM region contains Ϸ1 HSC (4) and is capable of an autonomous expansion of HSC numbers (2, 5) . We therefore tested the capacity of isolated E11.5 AoD and AoV explants to expand HSCs. After 72 h of culture, small fractions of AoD and AoV were transplanted into adult irradiated mice (0.3 e.e. per recipient). The AoV demonstrated a robust capacity to expand HSCs: 18 of the 20 mice that received cultured AoV were successfully repopulated (Fig. 7B) . In contrast, none of the , and dorsal (AoD) domains were assessed for the CFU-C activity before (0 h) and after (72 h) explant culture by using the colony-forming-unit methylcellulose (MC) assay. Leftmost bars show that the E11.5 Ao in isolation is capable of maintaining CFU-Cs in organ culture conditions Rightmost bars show that subdissected AoV expands the number of CFU-Cs after 72 h in culture; whereas the number of the CFU-Cs derived from the AoD is decreased after the culture. In each experiment, triplicate 35-mm dishes were inoculated with 0.5 e.e. of tissue; colonies were scored after 8 days. Error bars indicate SEM of three independent experiments. BFU-E, burst forming unit-erythroid; CFU, colony forming unit; Mac, macrophage; GM, granulocyte/macrophage; GEMM, granulocyte/erythroid/macrophage/megakaryocyte. e.e. indicates embryo equivalent of the tissue plated in MC culture per dish.
20 mice that received cultured AoD transplants were repopulated (Fig. 7B ).
Discussion
The AGM region plays an important role in the development of definitive HSCs in the mammalian embryo (2, (4) (5) (6) . It has an autonomous capacity to generate HSCs in culture conditions before colonization of the fetal liver (2) . Within the AGM region, the first HSCs emerge in the Ao (22) . Hematopoietic clusters attached to the ventral aortic endothelium have been observed in various vertebrate species, leading to speculation that definitive hematopoiesis originates ventrally in the Ao (7) (8) (9) (10) . Recent publications suggested a ventral subendothelial origin for definitive HSCs (11, 12) ; however, an endothelial origin of HSCs cannot be ruled out (12, 15, 16) . Of note, in addition to commonly observed ventral clusters, we found that intraaortic hematopoietic clusters in the mouse embryo, although with lower frequency, are also attached to the lateral and dorsal luminal surfaces of the E11.5 Ao.
To investigate the dorsoventral polarity in HSC development, we bisected Ao into the AoD and AoV and assessed the presence of CFU-Cs and HSCs using functional assays. Given the migratory nature of hematopoietic cells, this approach may not necessarily indicate the precise origin of these cells. Therefore, we also exploited an explant culture system previously used to model generation of HSCs in the embryo to assess the potential of AoD and AoV to support CFU-C and HSC activities (2, 4) .
Interestingly, we found that CFU-C content within the AoD and the AoV is not considerably different. However, these two domains have significantly different capacities to support and expand CFU-Cs. The number and lineage differentiation capacity of CFU-Cs after culture of AoD is dramatically reduced as compared with CFU-Cs supported by the AoV where they undergo expansion.
Another indication that the AoV is distinctly involved in development of the definitive hematopoietic system came from measurement of the HSC content in the E11.5 AoD and the AoV by using the long-term repopulation assay. We found that an absolute majority of HSCs were located within the AoV. Finally, critically important evidence came from the explant culture assay. We found that at E10.5, when HSCs have not yet emerged in vivo, the AoV, but not AoD, has an exclusive autonomous capacity to initiate HSCs. Furthermore, by E11.5, when the first HSCs appear in the AGM region in vivo, only the AoV, but not AoD, is capable of expansion of HSCs. These data demonstrate that the AoV plays an important role in the generation of HSCs. Recent publications propose both an endothelial and subendothelial/mesenchymal origin of HSCs in the AGM region (6, 11, 12, 23) ; however, the exact identity of cells in the AoV that give rise to HSCs is yet to be established. None of the published data rule out a possibility that the ancestors that develop into functional HSCs migrate to the AoV from the yolk sac (24) (25) (26) .
In summary, we demonstrate a dorsoventral polarity for the generation of definitive HSCs within the AGM region. We directly show a functional association of HSC development with the ventral floor of the Ao. Our data indicate that all elements required for the initiation and expansion of HSCs are present in the AoV and cumulatively constitute a functional niche for HSC development.
Materials and Methods
Mice. C57BL/6xCBA F1 mice were housed and bred in animal facilities at the University of Edinburgh. Donor tissues from CD45.2/CD45.2 embryos were isolated and transplanted into irradiated CD45.1/CD45.1 or CD45.1/CD45.2 adult recipients (Ն6 weeks of age) as described (4) . The day of discovery of the vaginal plug was designated as day 0.5. Embryos were scored according to Thelier criteria [for example, E11.0-E11.5 (41-47 somite pairs) is equal to stages 18 and 19] (http://genex.hgu. mrc.ac.uk/intro.html). Animals were kept in compliance with Home Office regulations.
AGM Dissection. The AGM region was dissected from E10.5-E11.5 embryos into 7% FCS/PBS by using sharpened tungsten 
